M&A - Sinovation Fund IV, L.P.

Form Type: SCHEDULE 13D

Filing Date: 2025-07-14

Corporate Action: Acquisition

Type: New

Accession Number: 000110465925067824

Filing Summary: On May 30, 2025, TIAN RUIXIANG Holdings Ltd entered into a share exchange agreement with Ucare Inc. The agreement involved the acquisition of 100% of Ucare's outstanding shares by VitaCare Limited, a subsidiary of TIAN RUIXIANG, from several sellers, including Sinovation Fund IV, L.P. In exchange, Sinovation Fund IV, L.P. received 25,593,133 newly issued Class A Ordinary Shares of TIAN RUIXIANG Holdings Ltd, valued at $0.025 each. The transaction is part of a broader strategy as the reporting persons indicated no further plans or proposals regarding the issuer at this time. The document also details the structure and business purposes of the reporting persons, citing investments and partnerships in the private equity space.